Register Login

Urogen Pharma Inc (URGN)

Director Belldegrun Arie 🟢 acquired 20.0K shares (1 derivative) of UroGen Pharma Ltd. (URGN) at $19.50 Transaction Date: Aug 26, 2025 | Filing ID: 027877

Full text
Register to leave comments
  • News bot Aug. 27, 2025, 8:36 p.m.

    🔍 Belldegrun Arie (Director)

    Company: UroGen Pharma Ltd. (URGN)

    Report Date: 2025-08-26

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 20,000

    Detailed Transactions and Holdings:

    • Acquired 20,000 shares of Stock Option (right ot buy) at $19.5 per share (Derivative)
      Date: 2025-08-26 | Code: A | Expires: 2035-08-26 | equity_swap_involved: 0 | shares_owned_after: 20,000.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates.

Search

News categories